- 250
- 263 749
OncBrothers: Practice-Changing Cancer Discussions
United States
เข้าร่วมเมื่อ 14 มิ.ย. 2022
On a mission to disseminate information to the community and bridge the gap between academia and community oncology in this rapidly changing field of hematology & oncology. Drs. Rahul & Rohit Gosain interview world-renowned hematologists/oncologists to present the practice-changing data in a small bite-sized format where one could immediately apply that information in their daily practice to provide the best cancer care to their patients close to home.
How to Approach and Treat Pancreatic Cancer
Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rohit and Rahul Gosain are joined by Dr. Eileen O'Reilly, a leading medical oncologist and section head of hepatobiliary and pancreatic cancer at Memorial Sloan Kettering Cancer Center. Together, they delve into the complex treatment landscape of pancreatic cancer.
Episode Highlights:
• The initial workup for newly diagnosed pancreatic cancer patients, including the importance of imaging and genetic testing.
• Treatment paradigms for early-stage, borderline resectable, and metastatic pancreatic cancer.
• The role of multi-agent chemotherapy, including modified FOLFIRINOX and gemcitabine-nab-paclitaxel.
• Insights into managing patients with high bilirubin levels and the considerations for dose adjustments.
• The emerging role of targeted therapies and the significance of comprehensive genetic testing in treatment decisions.
Join us as we explore the latest standards of care, the importance of a multidisciplinary approach, and the potential of new therapies in improving outcomes for patients with pancreatic cancer.
Don't forget to like, subscribe, and check out our other episodes for more insights on oncology topics, conference highlights, and recent treatment approvals!
Website: www.oncbrothers.com/
X/Twitter: oncbrothers
Contact us at info@oncbrothers.com
Episode Highlights:
• The initial workup for newly diagnosed pancreatic cancer patients, including the importance of imaging and genetic testing.
• Treatment paradigms for early-stage, borderline resectable, and metastatic pancreatic cancer.
• The role of multi-agent chemotherapy, including modified FOLFIRINOX and gemcitabine-nab-paclitaxel.
• Insights into managing patients with high bilirubin levels and the considerations for dose adjustments.
• The emerging role of targeted therapies and the significance of comprehensive genetic testing in treatment decisions.
Join us as we explore the latest standards of care, the importance of a multidisciplinary approach, and the potential of new therapies in improving outcomes for patients with pancreatic cancer.
Don't forget to like, subscribe, and check out our other episodes for more insights on oncology topics, conference highlights, and recent treatment approvals!
Website: www.oncbrothers.com/
X/Twitter: oncbrothers
Contact us at info@oncbrothers.com
มุมมอง: 108
วีดีโอ
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
มุมมอง 1.2K7 ชั่วโมงที่ผ่านมา
In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Neil Iyengar, a medical oncologist from Memorial Sloan Kettering Cancer Center, to discuss the critical role of nutrition and exercise in cancer care and recurrence prevention. They tackle common questions from cancer survivors about lifestyle modifications that can help reduce the risk of canc...
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
มุมมอง 3K16 ชั่วโมงที่ผ่านมา
In this episode of the Oncology Brothers podcast, hosts Drs. Rohit and Rahul Gosain welcome Dr. Pamela Kunz, a world-renowned medical oncologist from the Yale Cancer Center, to discuss the complex landscape of neuroendocrine tumors (NETs). Join us as we explore: • The classification of neuroendocrine tumors based on grade, histological features, and the significance of KI-67. • The role of ...
Palliative Care Management in Cancer | Onc Brothers
มุมมอง 2.9Kวันที่ผ่านมา
In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by esteemed palliative care experts Dr. Janet Abrahm from Dana-Farber Cancer Institute and Dr. Ishwaria Subbiah from Sarah Cannon Research Institute. Together, they delve into the critical topic of palliative care, exploring its evolution from a focus on end-of-life care to an integral part of cancer ...
How to Approach to Ovarian Cancer from Community Oncology Perspective
มุมมอง 2.8K21 วันที่ผ่านมา
In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain welcome Dr. Martina Murphy, an Associate Professor of Medicine and Senior Associate Dean of Graduate Medical Education at the University of Florida, to discuss the current landscape of ovarian cancer. Join us as we dive into the critical aspects of diagnosing and managing ovarian cancer, including: • The impor...
How to Approach to Endometrial Cancer from Community Oncology Perspective
มุมมอง 2.2K28 วันที่ผ่านมา
Join us for an insightful episode of the Oncology Brothers podcast as we dive deep into the world of gynecologic oncology, focusing specifically on endometrial cancer. Hosted by Drs. Rohit and Rahul Gosain, this episode features Dr. Shannon Westin, a Professor of Gynecology, Oncology, and Reproductive Medicine at the MD Anderson Cancer Center. In this episode, we explored: • The different his...
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
มุมมอง 2.9K28 วันที่ผ่านมา
In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain dive into the recent FDA approval of tarlatamab, a groundbreaking bispecific antibody for patients with extensive stage small cell lung cancer. Joined by Dr. Misty Shields from Indiana University, they explore the DeLLphi-301 study design, the efficacy of tarlatamab, and the operational challenges associated wit...
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
มุมมอง 2.3Kหลายเดือนก่อน
Welcome to another episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain dive into the recent approval of Durvalumab in the perioperative settings for non-small cell lung cancer, based on the AEGEAN trial. Join us as we welcome Dr. Sandip Patel, a medical oncologist from UCSD, and Dr. Mara Antonoff, a thoracic surgeon from MD Anderson, to discuss the impli...
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC
มุมมอง 2.6Kหลายเดือนก่อน
Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Stephen Liu, Associate Professor and Director of Thoracic Oncology at the Georgetown Lombardi Comprehensive Cancer Center. Together, they dive into the latest findings from ESMO 2024, focusing on key studies in lung cancer that every community oncologist should be aware of. Episode Hig...
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
มุมมอง 2.2Kหลายเดือนก่อน
In this episode of the Oncology Brothers Podcast, hosts Drs. Rohit and Rahul Gosain welcome Dr. Shernan Holtan from Roswell Park Comprehensive Cancer Center to discuss the recent approval of Axatilimab, a novel monoclonal antibody for the treatment of chronic graft-versus-host disease (GVHD). Join us as we explore the differences between acute and chronic GVHD, the challenges faced by community...
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
มุมมอง 2.1Kหลายเดือนก่อน
In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Mikkael Sekeres, Professor of Medicine and Chief of the Division of Hematology at the University of Miami. Together, they explore the complex landscape of acute myeloid leukemia (AML), discussing the latest advancements in diagnosis, treatment options, and risk stratification. Key topics includ...
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
มุมมอง 2.7Kหลายเดือนก่อน
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
มุมมอง 2.9Kหลายเดือนก่อน
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
มุมมอง 3.7Kหลายเดือนก่อน
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
มุมมอง 3K2 หลายเดือนก่อน
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
มุมมอง 1.9K2 หลายเดือนก่อน
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
มุมมอง 1.7K2 หลายเดือนก่อน
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
มุมมอง 1.7K3 หลายเดือนก่อน
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
มุมมอง 1.9K3 หลายเดือนก่อน
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
Role of Cardiology in Cancer Treatment: Cardio-Oncology
มุมมอง 2.2K3 หลายเดือนก่อน
Role of Cardiology in Cancer Treatment: Cardio-Oncology
How to Treat Early Stage Non-Small Cell Lung Cancer
มุมมอง 1.9K3 หลายเดือนก่อน
How to Treat Early Stage Non-Small Cell Lung Cancer
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
มุมมอง 2.6K3 หลายเดือนก่อน
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
มุมมอง 2K4 หลายเดือนก่อน
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
มุมมอง 2.5K4 หลายเดือนก่อน
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
มุมมอง 3.2K4 หลายเดือนก่อน
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
มุมมอง 2.5K5 หลายเดือนก่อน
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
มุมมอง 3.7K5 หลายเดือนก่อน
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
มุมมอง 4.5K5 หลายเดือนก่อน
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
Multidisciplinary Approach for Rectal Cancer - Discussion with Dr. Deb Schrag & Dr. Krishan Jethwa
มุมมอง 2.3K5 หลายเดือนก่อน
Multidisciplinary Approach for Rectal Cancer - Discussion with Dr. Deb Schrag & Dr. Krishan Jethwa
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
มุมมอง 1.6K5 หลายเดือนก่อน
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
Perfect👏🏻👏🏻
hi thanks for the clips please add Sarcoma , Metastatic breast cancer and latest of ALL to your upcoming discussions!
Holistic approach please, not cut and burn. Big pharma always? Or perhaps not.
Really thanks for this topic ... hope to see more of net, nec and ALL , rectum , ... thanks
Thank you for this conversation. It will be great if we can discuss topics like cancer related fatigue and pain in general. This helps community oncologists to manage symptoms especially when we don't have access to palliative care service. Thank you
My husband will be getting tarlatamab in about 1 1/2 weeks. Hopefully he will be able to get histotripsy on his liver as well.
hello, where do you live? I wonder how you got the medicine? My 39-year-old brother has small cell lung cancer. liver met. No medicine worked. We are in Turkey and this medicine is not available here yet. We cannot get it ourselves. Does your husband also have small cell lung cancer? How did you manage the process?
@GülşahKandemir-h1l We are in the USA. My husband will be the second person to get tarlatamab in our area. If you are referring to the histotripsy for the liver, it is not a medicine. It is a procedure using ultrasound. We are not sure yet where he would go for that. I pray the best for your brother.
@@windybassham3130 I wish the best for everyone who is looking for a cure. Lung cancer has metastasized to the liver. I hope treatment starts in Turkey as soon as possible. I hope your husband gets his best healthy life.
As always this is pure Gold!
Very helpful. Thank you.
Zulauf Ferry
I am a medical oncologist from Pakistan. I will say ur vidoes are amazing, watching them regularly. Learnt alot especially from the algorithm. Unfortunately Tx are for well developed countries. I would request you to involve Low income countries and ask them real world treatments they give and find the gaps
I am a medical oncologist from Pakistan. I will say ur vidoes are amazing, watching them regularly. Learnt alot especially from the algorithm. Unfortunately Tx are for well developed countries. I would request you to involve Low income countries and ask them real world treatments they give and find the gaps
Lois Shoal
Great work sir
Standard of care? How sad . Treating any and all cancer types using standard of care is like a cop showing up after the shooting is over … Treating radical cell division (cancer ) by trying to kill the cancer with radiation etc. instead of just cutting off what feeds the cancer and just starving it. Cancer feeds on only two foods Glutamine and glucose ( sugar ) thru fermentation …cut the carbs and feed your body on ketones Cancer can’t feed on ketones
Harris Thomas Perez Sandra Williams Frank
This was incredibly helpful and educational. Is there any new data regarding Nivo-AVD in pediatrics that I can look up for AS NSCHL in teens? I know it’s now the frontline for patients over 60 but curious if newer data shows it to be safe for the younger group as this video/research was over a year ago? Thanks for your channel and all you share
Keep it up, this is excellent.
My low risk mugs is now smoldering myeloma
Thank you so much for your great discussion
Thank you for telling the truth,the onco standards are 5 years after treatment is considered a cured case,but then the damaged cardio issues kill the patient,BUT the onco system says,0 NO this patient didnt die from cancer they died from a badly damaged cardiac system So ypu cant blame us oncos,,all while our onco system gained millions $$$$$$,,my elder father was caught by this trap, lucky i was able to stop this greedy process b4 it killed him
Amazing video!!!
Great overview, it would be great to have one final summary slide.
Hi. I’m 43 and I just was diagnosed with invasive lobular breast cancer with triple positive and BRCA1. Tumor size 8mm on MRI, 5mm on ultrasound. Just had a double mastectomy and waiting on pathology still after surgery to confirm size and if it has spread to lymph nodes. Seems rare to be lobular and HER2. Treatment with no spread is planned for 12 weeks of taxol and herceptin for 12 months with tamoxifen after. Any advice? Do you offer consults?
Look at cancer as a metabolic disease. You doctors need to watch dr seyfried
Thank you 🙏🏻
what about a elevated Kappa FLC, plus a high d-dimer (900)?
That was great. Thank you. When are you going to do the NET p and GI treatment with Mark Lewis? He is great. Can´t wait. I listen to you guys almost daily in Spotify
Next standard of care💪
I'm kappa light chain MGUS, but it's just 38.69, ratio 3.06. At what point would a bone marrow biopsy be done? When my ratio reaches 100? I understand the "watch and wait" in MGUS and SMM, but I thought a baseline BMB was standard after MGUS diagnosis via serum.
Thanks! Excellent discussion
Thank you!
I'm new here looking for herbal Dr about my urine but to my greatest surprises #drdaro Herb 🌿 cure fast
I'm new here looking for herbal Dr about my urine but to my greatest surprises #drdaro Herb 🌿 cure fast
I've been just diagnosed with rectal cancer after a biopsy during my colonoscopy. So far I've had a CT scan that showed 2 lymph nodes one 5mm and the other 6 with no spread to any organs. The Carcinoma is in the mid rectal area 5cm in length and I believe it is the MSS type tumor. I'm getting a MRI the second week of June I believe to get a better look at the lymph nodes. From what my surgeon said, I will get chemo/radiation, then if it didn't totally disappear which I don't think it would from that, I would get the surgery with an ileostomy. Then most likely chemo after that. All this seems like overkill to me. I'm so unsure if what they are planning is the best thing to do. Do you have any input or questions I should ask my Oncologist and Radiologist..
Everything from pharma is trash.
I was enrolled in manifest-2 protocol in Rome. My life became miserable because I was always ill. I stopped after the virus herpes zoster was riactivated and I suffered a sever facial paralysis. After a year I already have a parcial paralysis and balance problems beacause the VII and VIII cranial nerves were severy injured. I accepted to be enrolled because the doctor told me that otherwise I was going to die for leukemia. That was not true! I didn't have the intermediate-1 grade of myelofibrosis! I only had pre-myelofibrosis! Now I am well cured for pre-myelofibrosis in another roman hospital, only with oncocarbide and booldlettings when necessary, exactly as before I was enrolled in Manifest-2 protocol. I have never have anemia, sweeting or other sintomi, except a bit of fatigue. I've spent 10 thousand euros for the cures. Now I've filed a lawsuit against the hospital. But the law in Italy is really slow and I'll wait 10 years to have justice. The bad news is that I am hughly and parcial disabled, the good news is that I'm not going to die soon as I was told by the doctor who enrolled me in manifest-2!
Hope for a cure someday. 🙏
Hello , can i get this powerpoint presentation ? Kindly consider sharing it for educational purpose😊
Excellent, thanks for doing this!
Thank you for putting these focused talks on various oncology topics. I’m a relatively new NP in a Hem-Onc practice. This channel is a gold mine 🙏🏼
I'd like more info, my husband was diagnosed in 2017 without biopsy... he chose to do nothing with a PSA of 80 & rising . His PSA is now over 200 & PET Scan shows it's spread to bones & lymph. PLEASE HELP, NEED ADVICE ON WHAT TO DO NOW, I don't want to loose him !
Really would not want to be her patient
Thank you!
if your platform allows questions to be answered, how we may treat lung adenocarcinoma, T3N3MO, ALK POSITIVE?
Thanks for onco brothers...❤
Dr. Pal is my Dr. and he’s amazing!
where is he located?
handsome doctor
What is a better treatment in 2024 radiation or surgery
Lots of choices depending on Gleason Scores and retention of cancer cells in or out of prostate. HIFU Tulsa pro Keep the study going
End organ damage? What organs are you are talking about?
Kidney damage from the light chain proteins in the urine.
They mean kidney damage, due to light chain (proteins) deposits, that are dumped in the urine. They also may be referring to amyloid proteins in the heart (Amyloidosis) and kidneys.
Excellent